Facebook Pixel Code

Cipla Share Price

NSE
BSE
FUT
OPT

Here's the live share price of Cipla along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,530.20 Closed
0.29₹ 4.4
As on Nov 14, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Cipla Price Performance

Today's LowToday's High
₹1,523.00₹1,534.60
₹1,530.20
52 Weeks' Low52 Weeks' High
₹1,310.05₹1,672.20
₹1,530.20
Open Price
₹1,525.20
Prev. Close
₹1,525.80
Volume
30,581

Over the last 5 years, the share price of Cipla has gained 15.44% CAGR. Over the past year, the corresponding return has been 2.00%.

Cipla’s current P/E of 22.72x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Breakout Stocks Screener.

Cipla Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Cipla
1.71-1.47-2.152.332.0010.6615.44
Sun Pharmaceutical Industries
3.766.196.932.83-0.6920.0027.86
Divi's Laboratories
-2.05-0.606.365.1413.5025.7713.60
Torrent Pharmaceuticals
7.469.306.2018.6123.9932.6423.06
Dr. Reddy's Laboratories
3.290.62-1.142.061.5412.555.02
Zydus Lifesciences
0.02-3.59-4.544.42-1.4730.5717.06
Lupin
4.246.064.86-0.822.0739.3517.79
Mankind Pharma
0.21-6.89-8.27-11.10-12.9716.789.75
Aurobindo Pharma
9.359.3013.390.68-1.6336.077.57
Alkem Laboratories
0.403.686.5811.123.1621.8516.03
Abbott India
1.66-2.73-11.90-3.527.0713.6313.43
Biocon
8.1216.8414.3721.6222.3012.79-1.08
Laurus Labs
1.5613.8416.1264.66105.4228.6328.06
Glenmark Pharmaceuticals
4.24-0.10-7.4331.0923.5263.7831.26
GlaxoSmithKline Pharmaceuticals
-4.35-10.32-10.50-13.880.8622.8611.42
Anthem Biosciences
-2.60-12.11-17.80-7.05-7.05-2.41-1.45
Ipca Laboratories
13.0714.579.265.32-2.7619.747.37
Ajanta Pharma
-0.035.54-5.88-2.45-11.7226.0119.60
Gland Pharma
-1.66-4.63-7.3125.283.301.770.10
J B Chemicals & Pharmaceuticals
7.2110.096.4213.288.0022.6130.39

Over the last one year, Cipla has gained 2.00% compared to peers like Sun Pharmaceutical Industries (-0.69%), Divi's Laboratories (13.50%), Torrent Pharmaceuticals (23.99%). From a 5 year perspective, Cipla has outperformed peers relative to Sun Pharmaceutical Industries (27.86%) and Divi's Laboratories (13.60%).

Cipla Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Cipla Stock Technicals

Moving Average

DaySMAEMA
51,510.591,519.09
101,519.11,524.77
201,556.721,535.95
501,548.161,541.61
1001,533.41,533.86
2001,505.111,517.96

Cipla Share Holding Pattern

In the latest quarter, Cipla saw a rise in promoter holding to 29.22%, while DII stake increased to 30.25%, FII holding fell to 24.54%, and public shareholding moved down to 15.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Cipla Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
2,10,00,0003.693,156.93
99,88,8401.251,501.62
60,98,5423.01916.79
60,00,0003.83901.98
54,00,0004.88811.78
38,36,9851.22576.81
35,50,0000.99533.67
35,00,0004.28526.16
34,95,0546.48525.41
29,00,0000.83435.96

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Cipla Futures

Price
  (%)
As on Invalid Date IST
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Cipla Options

Price
  (%)
Not traded today
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Cipla Corporate Actions

Date Time
Announcement
Nov 03, 2025, 10:08 PM ISTCipla - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 03, 2025, 9:12 PM ISTCipla - Announcement under Regulation 30 (LODR)-Acquisition
Oct 31, 2025, 12:06 AM ISTCipla - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Oct 30, 2025, 7:28 PM ISTCipla - Outcome Of Board Meeting Dated 30Th October, 2025
Oct 30, 2025, 7:22 PM ISTCipla - Announcement under Regulation 30 (LODR)-Press Release / Media Release

About Cipla

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19044.85 Cr. and Equity Capital is Rs. 161.52 Cr. for the Year ended 31/03/2025.

Management

  • Dr. Y K Hamied
    Chairman
  • Mr. Umang Vohra
    Managing Director & Global CEO
  • Mr. Kamil Hamied
    Non Exe.Non Ind.Director
  • Mr. Abhijit Joshi
    Non Exe.Non Ind.Director
  • Mr. Adil Zainulbhai
    Non Exe.Non Ind.Director
  • Dr. Balram Bhargava
    Independent Director
  • Dr. Mandar Vaidya
    Independent Director
  • Ms. Maya Hari
    Independent Director
  • Mr. P R Ramesh
    Independent Director
  • Mr. Robert Stewart
    Independent Director
  • Ms. Sharmila Paranjpe
    Independent Director

FAQs on Cipla Share Price

What is the share price of Cipla?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cipla is ₹1,530.20 as on Nov 14, 2025.

What kind of stock is Cipla?

The Cipla is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.

What is the Market Cap of Cipla?

The market cap of Cipla is ₹123,605.15 Cr as on Nov 14, 2025.

What are today's High and Low prices of Cipla?

Today’s highest and lowest price of Cipla are ₹1,534.60 and ₹1,523.00.

What are the 52 Week High and 52 Week Low of Cipla?

The 52-week high/low is the highest and lowest price at which Cipla stock has traded in the past 52-week or nearly a year. The 52-week high of Cipla is ₹1,672.20 and 52-week low of Cipla is ₹1,310.05 as on Nov 14, 2025.

How has the Cipla performed historically in terms of returns?

The Cipla has shown returns of 0.29% over the past day, -1.47% for the past month, -2.15% over 3 months, 2.0% over 1 year, 10.66% across 3 years, and 15.44% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Cipla?

P/E ratio of and PB ratio of Cipla are 22.72 and 3.96 on Nov 14, 2025. While the company gives a dividend yield of 1.05 per annum.

icon
Market Pulse